Helping Your Oncology Brand

Achieve Success

Helping Your Oncology Brand Achieve Success

Mohamed "Raz" Dewji Senior Director

LinkedIn Profile

Mohamed (“Raz”) Dewji is a clinical development and medical affairs, expert with over thirty years of experience within the global pharmaceutical industry, specifically within the oncology therapeutics arena. He has worked internationally for major global pharmaceutical companies, including BMS, Pfizer, GSK and AstraZeneca. Over the course of his career to date, Raz has held roles of increasing seniority and made significant leadership contributions to six oncology drug approvals for various cancer treatment settings: Taxol (BMS); Amifostine (US Bioscience); Sunitinib & Axitinib (Pfizer); Pazopanib (GSK); Osimertinib (AZ)